Thiazolo-pyridopyrimidines: An in silico evaluation as a lead for CDK4/6 inhibition, synthesis and cytotoxicity screening against breast cancer cell lines. - Shetty, Chaithra R.; Shastry, C. S.; P., Parasuraman; Hebbar, Srinivas (BioImpacts, 2024)